<ѻý>In RA, Little Risk for Recurrent Cancer With Biologic Treatmentѻý> Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
<ѻý>Study Finds More Later-Stage CRC Diagnoses During Pandemicѻý> Japanese registry data reveals increase in stage III colorectal cancer, drops in earlier disease Sep 22, 2021
<ѻý>Survey Says: Support Is Lacking for Cancer's Lingering Effectsѻý> Survivors report dissatisfaction with long-term support Sep 22, 2021
<ѻý>Angiogenesis Inhibitor Slows Extrapancreatic Neuroendocrine Tumorsѻý> Almost 7-month increase in median PFS with addition of axitinib to endocrine therapy Sep 21, 2021
<ѻý>Bifunctional Protein Shows Promise in HPV-Related Cancersѻý> Objective responses in 28% of pretreated patients, durable in most cases Sep 20, 2021
<ѻý>Sunitinib Effective in Very Rare Neuroendocrine Tumorѻý> The TKI boosted PFS in patients with malignant pheochromocytoma and paraganglioma Sep 20, 2021
<ѻý>Some Reassurance on Cancer Risk With RAI Therapy for Hyperthyroidismѻý> No overall risk increase in large meta-analysis, but higher risk seen for thyroid cancer Sep 17, 2021
<ѻý>Stanley Tucci's Tongue Cancerѻý> The Oscar-nominated actor opens up about his private battle Sep 13, 2021
<ѻý>9/11 Responders Face Higher Risk of Multiple Cancersѻý> Longer follow-up sheds light on the long-term consequences of exposure to disaster site Sep 10, 2021
<ѻý>Durable Responses With IL-15 Superagonist in Early Bladder Cancerѻý> Addition of N-803 led to better responses in BCG-unresponsive disease Sep 10, 2021
<ѻý>Cancer Patients, COVID-19, and Long-Term Effectsѻý> Preventing COVID sequelae can minimize disruption of cancer care, European study finds Sep 09, 2021
<ѻý>Cough, Cancer, PTSD: Two Decades of World Trade Center Studiesѻý> Research has revealed the fallout of response to a crisis Sep 09, 2021
<ѻý>Liver Toxicity in Gene Therapy Trials Could Merit Stricter Entry Criteriaѻý> FDA panel weighs in on lower vector doses and role of animal studies Sep 03, 2021
<ѻý>FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risksѻý> Use for inflammatory conditions limited to those who fail on TNF blockers Sep 01, 2021
<ѻý>Study Confirms, Clarifies Excess Mortality in Testicular Cancer Survivorsѻý> Platinum-based chemotherapy, RT increased mortality risk of second cancers, other causes Aug 19, 2021
<ѻý>FDA Grants Tissue-Agnostic Approval to Dostarlimab for dMMR Tumorsѻý> Overall response rate of 41.6% in various tumor types with mismatch repair deficiency Aug 18, 2021
<ѻý>Medicare's Radiation Oncology Payment Model Vexes Oncology Communityѻý> Participation required for certain radiation oncology practices starting next January Aug 10, 2021
<ѻý>Higher Prices, No Difference in Resource Use at NCI Cancer Centersѻý> Negotiated facility prices, not surgeon costs, appeared to drive the differences Aug 03, 2021
<ѻý>Improved Survival in Metastatic Uterine Cancer With Hysterectomy Plus Chemoѻý> Data extend surgery's advantage from locally advanced to distant metastases Jul 29, 2021
<ѻý>Call in the T-Cell Cavalry to Fight COVID in the Immunocompromisedѻý> Preliminary research suggests immunotherapy could play role in protecting vaccine non-responders Jul 29, 2021
<ѻý>More Data Support Active Surveillance for Small Renal Massesѻý> Most patients avoided surgery with no metastasis, better focus on aggressive disease Jul 27, 2021
<ѻý>Shingrix OK'd for Immunocompromised Adultsѻý> CDC's vaccine committee currently discussing vaccine for this population, manufacturer says Jul 26, 2021
<ѻý>A Patient Care App Diagnosed Me With Cancerѻý> No one should receive a serious diagnosis this way -- not even a doctor like myself Jul 16, 2021
<ѻý>Raise a Glass? Study Tallies Cancer Cases From Boozeѻý> Heavy drinking habits accounted for about half of new alcohol-associated cases Jul 13, 2021
<ѻý>Empathy: The Most Critical Skill in Medicineѻý> Caring for a patient means putting yourself in their shoes Jul 09, 2021 podcast
<ѻý>Response Soars With Anti-PD-1 Drug for HER2-Positive Stomach Cancerѻý> Almost 50% relative increase in ORR with pembrolizumab plus trastuzumab and chemotherapy Jul 08, 2021
<ѻý>PD-1 Inhibitor Boosts Survival in Treated Esophageal Cancerѻý> Benefit with China-developed tislelizumab in all patients and EU-North American subgroup Jul 06, 2021
<ѻý>Woman Loses 6-Year Battle With Mouth Tumorѻý> Rare ameloblastoma rapidly recurs and metastasizes despite numerous radical excisions Jul 04, 2021
<ѻý>IVF Babies at No Increased Risk of Childhood Cancersѻý> No associations seen with intracytoplasmic sperm injection or frozen embryo transfer, study found Jul 02, 2021
<ѻý>House Members Argue for Puerto Rico Coal Plant Shutdownѻý> Plant is releasing toxic coal ash, sickening the nearby community, lawmakers and witnesses say Jul 01, 2021
<ѻý>'Clinically Meaningful' Survival Gain in Neuroendocrine Tumorsѻý> Near 1-year improvement with radionuclide agent misses statistical significance Jul 01, 2021
<ѻý>Adjuvant Combo Boosts Survival in Resected Pancreatic Cancerѻý> Four-month gain in OS with the addition of nab-paclitaxel to gemcitabine Jun 30, 2021
<ѻý>Do 'Robots' Offer Any Clear Surgical Advantage?ѻý> Review says no, and Vinay Prasad believes it's a sobering reflection on medical technology Jun 28, 2021 video
<ѻý>Adding PD-1 Inhibitor Shows Promise in Potentially Resectable HCCѻý> "Safe and successful conversion therapy" with hepatic arterial infusion chemo plus sintilimab Jun 28, 2021
<ѻý>Hold Off on Approving Anal Cancer Drug, Advisors Tell FDAѻý> ODAC recommends deferring approval of new PD-1 inhibitor until confirmatory trial results are in Jun 24, 2021
<ѻý>Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survivalѻý> News, features, and commentary about cancer-related issues Jun 16, 2021
<ѻý>The FDA Is Failing the American Peopleѻý> The agency's recent decision to approve aducanumab offers more evidence of a broken system Jun 16, 2021
<ѻý>COVID Vaccine Protection; 'Until You Die From the Cancer'; What's Palliative Care?ѻý> News, features, and commentary about cancer-related issues Jun 10, 2021
<ѻý>Bispecific Antibody Active in NRG1-Positive Pancreatic Cancerѻý> Zenocutuzumab turns in promising results in early-phase trial involving multiple solid tumors Jun 10, 2021
<ѻý>Promising Early Data for Bladder-Sparing Cancer Treatmentѻý> Bladder-intact DFS at 1 year nears 90% for muscle-invasive bladder cancer Jun 09, 2021